DiabetesMine explores how long a person with diabetes can live without insulin and how they can prolong life.

Inhaled insulin is effective for controlling blood sugar levels in children with diabetes, providing them with a ...

Dr. Lily Ackermann discussed inpatient diabetes care, focusing on real-world decisions and personalized treatment using ...

Once-weekly insulin efsitora alfa (efsitora) is in development for the treatment of people with diabetes. The aim of the current study was to assess the efficacy and safety of once-weekly efsitora ...

Insulin efsitora alfa (efsitora), a once-weekly basal insulin, has the potential to reduce the treatment burden of people with type 2 diabetes who require insulin. We aimed to assess the efficacy and ...

An insulin pump delivers insulin in two ways: via a basal rate and bolus doses. A basal rate is a steady flow throughout the day and night, programmed based on units per hour and customizable for ...

However few trials have used basal insulin analogues as the basal insulin in the MDI group and individuals with established SH have often been excluded from prospective studies.

Basal/bolus regimens have been shown to result in lower fasting blood glucose levels with less nocturnal hypoglycemia than regimens that use intermediate-acting NPH insulin in children/adolescents ...

Across the three trials, efsitora demonstrated an overall safety profile comparable to two of the most commonly used daily basal insulin therapies for type 2 diabetes.

Once-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 Diabetes — Insulin efsitora may potentially change the management paradigm, researcher says ...